Tests a clot-removal device in people having a stroke
Tests the RapidPulse Aspiration System to remove brain clots in adults with stroke.
Plain-language title generated from the registry record
Registry title: Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions
Key facts
- Where
- Istanbul, TürkiyeSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06029491, who can take part
Where in Türkiye
- Istanbul Aydan Universitesi VM Medical Park Florya HastanesiIstanbul, TürkiyeTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- RapidPulse, Inc
- Trial code
- NCT06029491
- Record updated
- 21 October 2026
- Original description
The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.Read full original descriptionShow less
Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions (TURBO)
The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.
Inclusion: Age 18 to 85 years; Clinical diagnosis of acute ischemic stroke with NIH Stroke Scale (NIHSS) score ≥ 6; Able to be treated within 8 hours of symptom onset or last known normal (LKN); Able to be treated within 120 minutes from the time of the qualifying baseline CT/MR image; Pre-morbid Modified Rankin Scale (mRS) score 0-1; Angiographic confirmation of large vessel occlusion (LVO) in the anterior (intracranial ICA or MCA M1 or M2 segments) or posterior circulation (vertebral or basilar arteries) as confirmed by digital subtraction angiography (DSA) irrespective of IV thrombolysis administration; Candidate to receive treatment with ADAPT technique (Direct Aspiration First-Pass Technique).
Exclusion: Intracranial Hemorrhage (ICH); Alberta Stroke Program Early CT Score (ASPECTS) <6 or (PC-ASPECTS <8 on CT angiography source images or DWI MRI for posterior circulation stroke); Intracranial Atherosclerotic Disease (ICAD); Significant mass effect and/or midline shift; Multiple or tandem occlusions; Life expectancy less than 6 months.